Specificities of broadly neutralizing anti-HIV-1 sera

被引:21
作者
Binley, James [1 ]
机构
[1] Torrey Pines Inst Mol Studies, San Diego, CA USA
关键词
gp120; gp41; HIV-1; neutralization; IMMUNODEFICIENCY-VIRUS TYPE-1; HUMAN MONOCLONAL-ANTIBODIES; PROXIMAL EXTERNAL REGION; MEMORY B-CELLS; PASSIVE TRANSFER; V3; LOOP; GP120; GLYCOPROTEIN; ENVELOPE PROTEINS; HIV-1; ENVELOPE; BINDING-SITE;
D O I
10.1097/COH.0b013e32832e06fe
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Purpose of review Effective vaccine-elicited immunity against HIV-1 infection will likely require broadly neutralizing antibodies to interrupt the fusion-promoting functions of the viral envelope glycoprotein spikes. Efforts in this area have, however, been fraught with challenges. The handful of existing broadly neutralizing monoclonal antibodies has provided information on some of the virus' sites of vulnerability, fueling a decade of structure-informed vaccine design. The fact that very few bnmAbs have been recovered to date illustrates the poor immunogenicity of these epitopes. Recognizing that progress may require more basic information, there has been a notable shift in the field toward identifying new chinks in HIV-1's armor. These efforts are based on the observation that some infected patients develop exceptionally broad serum neutralizing antibodies responses, a better understanding of which would be valuable for vaccine efforts aimed at eliciting similar specificities. Recent findings New mapping methodologies are now providing an appreciation of the incidence of specificities similar to the existing known bnmAbs as well as some intriguing insights into novel specificities. Summary The new information emerging from mapping efforts should help to sharpen efforts to isolate new bnmAbs and moreover, may provide crucial information for the rational design of novel vaccine candidates.
引用
收藏
页码:364 / 372
页数:9
相关论文
共 90 条
[1]   Human immunodeficiency virus type 1 Env with an intersubunit disulfide bond engages coreceptors but requires bond reduction after engagement to induce fusion [J].
Abrahamyan, LG ;
Markosyan, RM ;
Moore, JP ;
Cohen, FS ;
Melikyan, GB .
JOURNAL OF VIROLOGY, 2003, 77 (10) :5829-5836
[2]   HIV-1 envelope protein binds to and signals through integrin α4β7, the gut mucosal homing receptor for peripheral T cells [J].
Arthos, James ;
Cicala, Claudia ;
Martinelli, Elena ;
Macleod, Katilyn ;
Van Ryk, Donald ;
Wei, Danlan ;
Xiao, Zhen ;
Veenstra, Timothy D. ;
Conrad, Thomas P. ;
Lempicki, Richard A. ;
McLaughlin, Sherry ;
Pascuccio, Massimiliano ;
Gopaul, Ravindra ;
McNally, Jonathan ;
Cruz, Catherine C. ;
Censoplano, Nina ;
Chung, Eva ;
Reitano, Kristin N. ;
Kottilil, Shyam ;
Goode, Diana J. ;
Fauci, Anthony S. .
NATURE IMMUNOLOGY, 2008, 9 (03) :301-309
[3]   Human neutralizing monoclonal antibodies of the IgG1 subtype protect against mucosal simian-human immunodeficiency virus infection [J].
Baba, TW ;
Liska, V ;
Hofmann-Lehmann, R ;
Vlasak, J ;
Xu, WD ;
Ayehunie, S ;
Cavacini, LA ;
Posner, MR ;
Katinger, H ;
Stiegler, G ;
Bernacky, BJ ;
Rizvi, TA ;
Schmidt, R ;
Hill, LR ;
Keeling, ME ;
Lu, YC ;
Wright, JE ;
Chou, TC ;
Ruprecht, RM .
NATURE MEDICINE, 2000, 6 (02) :200-206
[4]   MOLECULAR PROFILE OF AN ANTIBODY-RESPONSE TO HIV-1 AS PROBED BY COMBINATORIAL LIBRARIES [J].
BARBAS, CF ;
COLLET, TA ;
AMBERG, W ;
ROBEN, P ;
BINLEY, JM ;
HOEKSTRA, D ;
CABABA, D ;
JONES, TM ;
WILLIAMSON, RA ;
PILKINGTON, GR ;
HAIGWOOD, NL ;
CABEZAS, E ;
SATTERTHWAIT, AC ;
SANZ, I ;
BURTON, DR .
JOURNAL OF MOLECULAR BIOLOGY, 1993, 230 (03) :812-823
[5]  
BERMAN P, AIDS VACC 08 C CAP T
[6]  
BIBOLLETRUCHE F, 2006, KEYST S X6 HIV VACC
[7]   Comprehensive cross-clade neutralization analysis of a panel of anti-human immunodeficiency virus type 1 monoclonal antibodies [J].
Binley, JA ;
Wrin, T ;
Korber, B ;
Zwick, MB ;
Wang, M ;
Chappey, C ;
Stiegler, G ;
Kunert, R ;
Zolla-Pazner, S ;
Katinger, H ;
Petropoulos, CJ ;
Burton, DR .
JOURNAL OF VIROLOGY, 2004, 78 (23) :13232-13252
[8]   Profiling the Specificity of Neutralizing Antibodies in a Large Panel of Plasmas from Patients Chronically Infected with Human Immunodeficiency Virus Type 1 Subtypes B and C [J].
Binley, James M. ;
Lybarger, Elizabeth A. ;
Crooks, Emma T. ;
Seaman, Michael S. ;
Gray, Elin ;
Davis, Katie L. ;
Decker, Julie M. ;
Wycuff, Diane ;
Harris, Linda ;
Hawkins, Natalie ;
Wood, Blake ;
Nathe, Cory ;
Richman, Douglas ;
Tomaras, Georgia D. ;
Bibollet-Ruche, Frederic ;
Robinson, James E. ;
Morris, Lynn ;
Shaw, George M. ;
Montefiori, David C. ;
Mascola, John R. .
JOURNAL OF VIROLOGY, 2008, 82 (23) :11651-11668
[9]   Redox-triggered infection by disulfide-shackled human immunodeficiency virus type 1 pseudovirions [J].
Binley, JM ;
Cayanan, CS ;
Wiley, C ;
Schülke, N ;
Olson, WC ;
Burton, DR .
JOURNAL OF VIROLOGY, 2003, 77 (10) :5678-5684
[10]   CRYPTIC NATURE OF ENVELOPE V3 REGION EPITOPES PROTECTS PRIMARY MONOCYTOTROPIC HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 FROM ANTIBODY NEUTRALIZATION [J].
BOUHABIB, DC ;
RODERIQUEZ, G ;
ORAVECZ, T ;
BERMAN, PW ;
LUSSO, P ;
NORCROSS, MA .
JOURNAL OF VIROLOGY, 1994, 68 (09) :6006-6013